HOME >> BIOLOGY >> NEWS
NHGRI selects sequencing centers

n worm; the flatworm Schmidtea mediterranea; 10 more species of fruit fly; four more species of fungi; and two ciliated microorganisms, Oxytricha trifallax and Tetrahymena thermophila. Details of when those sequencing projects will begin and what centers will participate in each project are being finalized.

"The availability of the human genome sequence, as well as other genomic resources, has profoundly affected biomedical research and thinking. Information about whole genomes is now available for the first time," said NHGRI's Associate Director of Extramural Research Jane Peterson, Ph.D. "Previously, scientists were limited to gaining such information from one gene at a time. By making complete sets of genes from different types of organisms available, we can learn much more about how genes are turned on and off, and how genes interact with each other. The possibilities are endlessly exciting."

To produce a comprehensive plan for the large-scale sequencing program that will yield the most insights into human biology, NHGRI recently instituted a new process for choosing target organisms for comparative sequencing. Rather than placing the entire responsibility for advocating for the sequencing of various organisms upon individual researchers, NHGRI has established three working groups comprised of experts from across the research community. Each working group will develop a well thought-out plan for sequencing organisms that advances knowledge in one of three scientific areas: understanding the human genome, understanding the genomes of major biomedical model systems and evolutionary biology of genomes. Direct requests from researchers will also continue to be accepted and considered together with the working group plans.

"We felt a need for a more coherent approach to selecting sequencing targets. To do so, we needed to establish a process to enable members of the research community to carefully consider and discuss all the alternative tar
'"/>

Contact: Geoff Spencer
spencerg@mail.nih.gov
301-02-0911
NIH/National Human Genome Research Institute
7-Nov-2003


Page: 1 2 3 4 5

Related biology news :

1. NHGRI launches Centers for Excellence in Ethical, Legal, and Social Implications Research
2. NHGRI adds 18 organisms to sequencing pipeline
3. NHGRI study may help scientists develop safer methods for gene therapy
4. NHGRI adds cow and dog to high priority list for sequencing model organisms
5. NHGRI funds two new centers of excellence in genomic science
6. NHGRI launches genome.gov
7. NHGRI prioritizes model organisms for sequencing
8. Whitehead Receives $35 Million Grant From National Human Genome Research Institute (NHGRI)
9. HHMI selects new clinical investigators
10. American Society for Microbiology selects Mass Media Fellows
11. National Science Board selects leading chemists to establish new Science and Technology Center

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: NHGRI selects sequencing centers

(Date:12/10/2014)... N.C. , Dec. 9, 2014  Wake Forest Baptist ... education building for its School of Medicine. Funding for ... larger capital campaign that will be publicly launched next ... be located in the former 60 series R.J. Reynolds ... Innovation Quarter. Construction will begin immediately with plans to ...
(Date:12/5/2014)... MOUNTAIN VIEW, Calif. , Dec. 4, 2014 ... and safety has boosted investments in new testing ... products has also given rise to a range ... driven by the requirements of Generation Y, which ... digital technologies. As a result, product development strategies ...
(Date:12/3/2014)... , Dec. 2, 2014 As part ... readers, Inception Technologies is pleased to announce the release ... for customers to collect the workforce data that they ... that have been left by existing readers. Many such ... interface, connectivity and modern technology. Older models force users ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 2Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 3Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market 4Inception Technologies to Release New Biometric Reader 2
(Date:12/17/2014)... (PRWEB) December 17, 2014 Gene ... that it has entered into a technology access ... (ADM) to apply DNA2.0’s proprietary protein engineering technology, ... process. , “We are extremely excited that the ... platform. This proprietary bioengineering technology has now ...
(Date:12/17/2014)... SOUTH SAN FRANCISCO, Calif. , Dec. 17, ... positive results of a Phase 2 study evaluating ... for the treatment of patients with severe, chronic ... the current standard of care, including topical steroids ... endpoint was percent change in Visual Analog Scale ...
(Date:12/15/2014)...  GlassesOff Inc. (OTCBB: GLSO) announced today the appointment ... director of the Company,s Board of Directors. ... its CEO until its acquisition by Stanley Black ... Recognized as the inventor of the first Wi-Fi-based Active ... -based RFID solutions focused on improving operational efficiency, safety ...
(Date:12/13/2014)... (PRWEB) December 12, 2014 Clarassance, a ... announced its new name: Therabron Therapeutics , Inc. ... and bronchioles (a type of structure in the lungs ... company’s mission to develop novel protein therapeutics for the ... directors decided to change the name to mark the ...
Breaking Biology Technology:ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4AeroScout Founder Joins GlassesOff's Board of Directors 2AeroScout Founder Joins GlassesOff's Board of Directors 3Maryland-based Biotech Company's Path Forward in Treating Respiratory Diseases Sparks Name Change 2
Cached News: